In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of my favorite stocks. Shares have jumped by more than 20,000% since then.

I believe we are about to do it again with this new AI project called Stargate

Thomas M. Moriarty net worth and biography

Thomas Moriarty Biography and Net Worth

EVP of CVS Health

Thomas Moriarty is the executive vice president, chief policy and external affairs officer and general counsel at CVS Health. In these roles, he manages the brand and reputation strategy for the company’s external affairs function, including corporate communications, the policy and government affairs teams and legal and regulatory departments. He joined the company in 2012.

He previously served as general counsel for Celgene Corp., as secretary and general counsel for Medco Health Solutions, as assistant counsel for Merck & Co., president for Global Pharmaceutical Strategies, assistant general counsel for Merial and as a chairman for Red Oak Sourcing.

Moriarty holds an undergraduate degree from Lafayette College and a law degree from the University of Virginia School of Law.

What is Thomas M. Moriarty's net worth?: The estimated net worth of Thomas M. Moriarty is at least $35.28 million as of December 15th, 2022. Mr. Moriarty owns 608,129 shares of CVS Health stock worth more than $35,277,563 as of November 23rd. This net worth estimate does not reflect any other investments that Mr. Moriarty may own. Learn More about Thomas M. Moriarty's net worth.
How do I contact Thomas M. Moriarty?: The corporate mailing address for Mr. Moriarty and other CVS Health executives is ONE CVS DR., WOONSOCKET RI, 02895. CVS Health can also be reached via phone at (401) 765-1500 and via email at [email protected]. Learn More on Thomas M. Moriarty's contact information.
Has Thomas M. Moriarty been buying or selling shares of CVS Health?: Thomas M. Moriarty has not been actively trading shares of CVS Health in the last ninety days. Most recently, Thomas M. Moriarty sold 137,466 shares of the business's stock in a transaction on Thursday, December 15th. The shares were sold at an average price of $98.36, for a transaction totalling $13,521,155.76. Following the completion of the sale, the executive vice president now directly owns 608,129 shares of the company's stock, valued at $59,815,568.44. Learn More on Thomas M. Moriarty's trading history.
Who are CVS Health's active insiders?: CVS Health's insider roster includes Lisa Bisaccia (EVP), Eva Boratto (Former CFO), Troyen Brennan (EVP), James Clark (SVP), Alexander Cunningham (Exec. VP & COO of Aetna business ), Daniel Finke (EVP), Joshua Flum (EVP), Shawn Guertin (Exec. VP & CFO ), Alan Lotvin (EVP), Edward Ludwig (Director), Karen Lynch (EVP), Larry Merlo (Director), Thomas Moriarty (EVP), Jonathan Roberts (COO), and Prem Shah (EVP). Learn More on CVS Health's active insiders.
Are insiders buying or selling shares of CVS Health?: In the last twelve months, CVS Health insiders bought shares 1 times. They purchased a total of 1,000 shares worth more than $53,880.00. In the last twelve months, insiders at the pharmacy operator sold shares 1 times. They sold a total of 29,473 shares worth more than $2,267,947.35. The most recent insider tranaction occured on May, 2nd when Director Edward J Ludwig bought 1,000 shares worth more than $53,880.00. Insiders at CVS Health own 0.2% of the company. Learn More about insider trades at CVS Health.
Information on this page was last updated on 5/2/2024.

Thomas M. Moriarty Insider Trading History at CVS Health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/15/2022	Sell	137,466	$98.36	$13,521,155.76	608,129
6/28/2022	Sell	138,654	$95.00	$13,172,130.00	626,273
5/10/2021	Sell	109,469	$86.00	$9,414,334.00	109,469
4/21/2021	Sell	103,423	$77.00	$7,963,571.00	103,423
3/29/2021	Sell	62,943	$76.15	$4,793,109.45	62,943
3/19/2021	Sell	49,211	$74.15	$3,648,995.65	12,778
10/2/2017	Sell	20,547	$81.17	$1,667,799.99	43,178
9/11/2017	Sell	90,267	$79.61	$7,186,155.87	70,102
10/1/2012	Buy	6,164	$48.67	$300,001.88

Thomas M. Moriarty Buying and Selling Activity at CVS Health

CVS Health Company Overview

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

Today's Range

Now: $58.01

$56.62

$58.04

50 Day Range

MA: $59.21

$53.19

$67.46

2 Week Range

Now: $58.01

$52.71

$83.25

Volume

10,428,506 shs

Average Volume

11,356,283 shs

Market Capitalization

$73.00 billion

P/E Ratio

14.72

Dividend Yield

4.77%

Beta

0.55

Bill Gates’s Next Big AI Bet: Stargate

From Brownstone Research | Ad